Global Health

Global Health Diluted EPS

The Diluted Earnings per Share of Global Health (MEDANTA.NS) as of Nov 19, 2026 is 20.68 INR. In the previous year, Diluted Earnings per Share was 17.94 INR — a change of 15.29% (higher).

Diluted EPS

20.68INR

YoY

15.29%

Last updated:

Diluted Earnings per Share of Global Health is 2026 20.68 INR. Diluted Earnings per Share of Global Health was 2025 17.94 INR. It decreases by 15.29% higher compared to the previous year.

The Global Health Diluted EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Diluted EPS
Date
Diluted EPS
Jan 1, 2019
1.91 INR
Jan 1, 2020
1.35 INR
Jan 1, 2021
1.14 INR
Jan 1, 2022
7.50 INR
Jan 1, 2023
12.13 INR
Jan 1, 2024
17.80 INR
Jan 1, 2025
17.94 INR
Jan 1, 2026
20.68 INR
The Global Health Diluted EPS history
YEARDiluted EPSYoY
20.68INR+15.29%
17.94INR+0.75%
17.80INR+46.74%
12.13INR+61.84%
7.50INR+559.39%
1.14INR-15.78%
1.35INR-29.19%
1.91INR+56.07%
1.22INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Global Health Stock analysis

What does Global Health do? Global Health Ltd. provides healthcare, pathology, and medical services through its Medanta brand, operating five hospitals in Delhi, Gurugram, Indore, Ranchi, Patna, and Lucknow, alongside six Mediclinic diagnostic laboratories. The company generates revenue by delivering treatments for conditions such as coronary artery disease, head and neck cancer, acute myeloid leukemia, and chronic kidney disease, alongside specialized services in cardiac surgery, nephrology, urology, and interventional cardiology. Its offerings include medicine delivery, lab tests & diagnostics, homecare, and telemedicine, targeting patients seeking advanced medical care across multiple specialties. Medanta serves urban and semi-urban segments in India, focusing on high-demand treatments and comprehensive healthcare solutions. The company monetizes through direct patient services at its hospitals and diagnostic centers, with revenue derived from procedures, consultations, and diagnostic tests. Treatments for chronic conditions like diabetes, hypertension, and bronchial asthma, as well as acute cases such as cerebral stroke and sepsis, form a significant portion of its service portfolio. Patients utilize Medanta’s telemedicine and homecare services for convenience, while its diagnostic labs provide lab tests & diagnostics to both in-person and remote clients. Revenue streams are driven by high-volume treatments and specialized medical expertise across its network of facilities. Medanta’s service mix includes cardiology, oncology, neurology, and orthopedics, with a focus on conditions like Parkinson’s disease, prostate cancer, and rheumatoid arthritis. The company’s revenue model relies on comprehensive care packages, including hospital stays, outpatient visits, and follow-up services. Its facilities in Delhi, Gurugram, and other cities cater to both private and government-affiliated patients, though the business description does not specify government contracts. The company’s diagnostic laboratories and telemedicine services expand its reach, enabling revenue from multiple touchpoints within the healthcare ecosystem. Global Health is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Global Health stock

Diluted Earnings per Share of Global Health is 20.68 INR in 2026.

Diluted Earnings per Share of Global Health changed from 17.94 INR to 20.68 INR, representing a 15.29% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Diluted Earnings per Share Global Health since 2006 – with annual values, charts, and detailed analysis.

Diluted EPS accounts for all potential shares from options, warrants, and convertible securities. It provides a more conservative per-share earnings measure.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Global Health

All Key Metrics — Global Health